Vivos Inc Stock Fundamentals
| RDGL Stock | USD 0.09 0.01 10.00% |
Vivos Inc fundamentals help investors to digest information that contributes to Vivos' financial success or failures. It also enables traders to predict the movement of Vivos OTC Stock. The fundamental analysis module provides a way to measure Vivos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vivos otc stock.
Vivos |
Vivos Inc OTC Stock Return On Equity Analysis
Vivos' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vivos Return On Equity | -1.17 |
Most of Vivos' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vivos Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Vivos Inc has a Return On Equity of -1.174. This is 95.1% lower than that of the Healthcare sector and 86.55% lower than that of the Medical Devices industry. The return on equity for all United States stocks is notably higher than that of the company.
Vivos Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vivos's current stock value. Our valuation model uses many indicators to compare Vivos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vivos competition to find correlations between indicators driving Vivos's intrinsic value. More Info.Vivos Inc is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vivos' earnings, one of the primary drivers of an investment's value.Vivos Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vivos' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Vivos could also be used in its relative valuation, which is a method of valuing Vivos by comparing valuation metrics of similar companies.Vivos is currently under evaluation in return on equity category among its peers.
Vivos Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.62 | |||
| Operating Margin | (67.68) % | |||
| Current Valuation | 15.27 M | |||
| Shares Outstanding | 359.89 M | |||
| Shares Owned By Insiders | 5.41 % | |||
| Price To Earning | 0.17 X | |||
| Price To Book | 9.01 X | |||
| Price To Sales | 598.62 X | |||
| Revenue | 14.89 K | |||
| Gross Profit | 2.89 K | |||
| EBITDA | (2.5 M) | |||
| Net Income | (2.53 M) | |||
| Cash And Equivalents | 1.99 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 295.76 K | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 12.71 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (963.82 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.84 | |||
| Market Capitalization | 24.65 M | |||
| Total Asset | 1.63 M | |||
| Z Score | 46.5 | |||
| Net Asset | 1.63 M |
About Vivos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivos Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos Inc based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. VIVOS INC operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Vivos OTC Stock
Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.